Looking to engage with our member community by contributing to ASAP’s content? Send your blog post, article draft, or idea to Kim Miller at kmiller@strategic-alliances.org
How do you develop therapies that will help capture part of the rare/orphan disease market that is expected to exceed $300 billion in 2030? It takes an ecosystem of seven players, explained Jeff Livingstone in his ASAP BioPharma Conference presentation last last month. Continue Reading
Influence is what helps build bridges when partners are at odds. “It is perhaps the hardest part of the job, but it is the part of the job that delivers the greatest value." The Rhythm of Business delivered a master class on the subject at the 2022 ASAP BioPharma Conference. Continue Reading
What's causing alliance managers to spend 70% of their time aligning stakeholders? competition for resources, organizational silos, lack of clarity on the partnership’s North Star, and changes in executive leadership, to name a few, according to participants in a recent ASAP roundtable. Continue Reading
What do your C-level execs want to know? What's the best way to deliver that information? And how do you do it quickly, so as not to waste your senior executive's precious time? Sally Wang, Katherine Kendrick and Drew Quinlan broke it down in ASAP's latest webinar. Continue Reading
According to our ASAP BioPharma Conference keynote speaker, the future for alliance managers is bright. In fact, their particular blend of skills and capabilities could just light their way up to the corner offices where the C-level executives live. Continue Reading
In a 2022 ASAP BioPharma Conference marked by record-breaking attendance, Alex Waldron, CEO of Wellinks, painted a picture of the very near future of digital health partnering that awaits all those working in the trenches of biopharma alliance management. If not now, then soon! Continue Reading
The answer to the conundrum of increasing complexity, diversity, and sheer numbers of biopharma partnerships? It just might be a strategy of complete and utter transparency with our partners, according to this year's speaker at the ASAP BioPharma Conference Leadership Forum. Continue Reading
Jim Mullen of Editas Medicine will tell ASAP BioPharma Conference attendees how to prevent intangible factors from derailing an alliance, including senior leadership turnover; asymmetries in knowledge, impact, size, or importance of the partner; or vague contract language, to name a few. Continue Reading
Novartis and Microsoft executives will demystify basic tech concepts, such as cloud-based solutions, tech stacks, and AI, as they explain what all biopharma alliance managers need to know about digital transformation—and why they need to understand it—at the ASAP BioPharma Conference Sept. 28–30. Continue Reading
Marketing should not be just an afterthought in partnering, says our guest contributor. Rather than being ad hoc and as-needed, it should form part of a coherent plan that is applied throughout an alliance's life cycle. Continue Reading
Among the relatively new frontiers for biopharma partnering is the realm of digital therapeutics and digital health. A keynote speakers at the 2022 ASAP BioPharma Conference says new technologies and new approaches have the potential to democratize healthcare and revolutionize partnering. Continue Reading
Patrick Heffernan and Geoff Woollacott of Technology Research Business, Inc. (TBR) laid out a plan for startups to be better ecosystem partners to the world's largest tech companies in ASAP's latest webinar. Continue Reading
